Vitrana
Vitrana is an AI-powered pharmacovigilance technology and services company serving global pharmaceutical companies, CROs, and life sciences organizations across 90+ countries. It offers the HiLIT platform — modular tools for case intake, processing, oversight, and regulatory submissions — built by former Oracle Argus Safety architects and now operating as a Parexel company.
- Company typePrivate
- Founded2008
- HeadquartersNoida, India
- Headcount251–500
- GTM typeB2B
- OfferingSoftware
What Vitrana does
Vitrana is a private pharmacovigilance (PV) technology and services company founded in 2008 (operating as Virtuous Transactional Analytics Private Limited, rebranded to Vitrana) and headquartered in Noida, India, with offices in Cranbury, NJ (US), Bangalore, and Sodegaura, Japan. The company builds AI-powered software for drug safety operations — case intake, processing, regulatory submissions, and compliance oversight — and serves global pharmaceutical companies, contract research organizations (CROs), and life sciences organizations across 90+ countries. Its core platform is HiLIT, a modular architecture comprising an Intake Suite (intelligent triage and ICSR generation across literature, web, email, and mobile channels), a Processing Suite (HiARSIC) for automated case workflows, an Oversight Suite branded as Quadrant (including SOAR natural language query, In-Line and Retro QC, and a PV Data Mart), and a Submissions Suite (HiDIS) for regional regulatory R3 compliance including RSI Management and TransformPV. The platform integrates with Oracle Argus Safety, ARISg, Medidata, Oracle Clinical, Salesforce, SAP, and major BI/ETL tools, and is 21 CFR Part 11 compliant. Vitrana monetizes through subscription/usage-based platform licensing, multi-year enterprise contracts, managed services (24/7 Follow the Sun), and professional services including implementation, upgrades, data migration, and specialized Japan/PMDA consulting. The company is led by former Oracle Health Sciences Global Business Unit architects who built the Argus Safety Suite, with 18+ years average leadership experience. In April 2026, Vitrana was acquired by Parexel (backed by EQT and Goldman Sachs Asset Management), and in May 2026 its automation capabilities were incorporated into the ParexelAI suite. Vitrana serves 30+ active enterprise customers (including Pfizer, Roche, Novartis, GSK, Lilly, Bayer, Gilead, Alexion, Otsuka, IQVIA, and BioClinica) and processes 15M+ reports annually with 18K+ platform users and 99%+ regulatory submission accuracy.
Vitrana firmographics
Firmographics- Name
- Vitrana
- Legal name
- Virtuous Transactional Analytics Private Limited
- Website
- https://vitrana.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Acquired
- Headcount range
- 251–500 employees
- Short description
- Vitrana is an AI-powered pharmacovigilance technology and services company serving global pharmaceutical companies, CROs, and life sciences organizations across 90+ countries. It offers the HiLIT platform — modular tools for case intake, processing, oversight, and regulatory submissions — built by former Oracle Argus Safety architects and now operating as a Parexel company.
- Ownership category
- akta.pro rank
Vitrana industry classification
Industry- Product category
- Pharmacovigilance Software
- NAICS
- Custom Computer Programming Services (541511), Other Computer Related Services (541519), Computer Systems Design Services (541512)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Programming Services (7371)
- akta.pro primary industry
- Pharmacovigilance & Drug Safety Software (HLAGAJAK)
- akta.pro secondary industries
- Pharmacovigilance, Drug Safety & Risk Management FSP (HLAGAOAF), Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF) (HLAGAKAH), Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)
Keywords
Where Vitrana is headquartered
LocationHeadquarters
- HQ city
- Noida
- HQ country
- India
- HQ region
- Asia
Offices4 records
Markets served
Vitrana business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Operations Software: AI-powered pharmacovigilance technology platform delivered as software solutions covering intake, processing, submissions, and oversight. Revenue generated through platform licensing, subscription, and usage-based models.
- Professional Services: Consulting services including PV regulatory compliance, safety database implementation and upgrades, data migration, project management, and validation services. Delivered by 270+ PV professionals with deep domain expertise.
- Managed Services: 24/7 managed services with 'Follow the Sun' model, application management, hosting, and support services for pharmacovigilance operations. Includes 'Build Your Team @ Vitrana' flexible engagement model.
- Japan Consulting Services: Specialized consulting for Japanese market including PMDA regulatory compliance, Argus Japan implementation, bilingual support, and Japan-specific system configurations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Custom enterprise pricing based on scope and requirements |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
Vitrana product offering
Product offeringCore offering
Vitrana develops and sells the HiLIT Platform, an AI-powered pharmacovigilance technology suite that automates adverse event case intake, processing, quality control, regulatory submissions, and compliance oversight for pharmaceutical companies and CROs. The platform integrates directly with Argus Safety and ARISg databases and includes specialized modules for AI-driven RSI management, regional R3 submissions, natural language querying (SOAR), and PV data analytics. In parallel, Vitrana delivers professional consulting, implementation, data migration, and 24/7 managed services to operate drug safety systems.
Product overview
Vitrana offers a unified platform-plus-modules architecture centered on the HiLIT Platform for pharmacovigilance operations. The core platform integrates with Argus Safety and ARISg safety databases, with specialized add-on modules: Intake Suite for intelligent case intake and data extraction (Literature, Web Forms, Mobile, Query Management); Processing Suite for automated case workflows; Oversight Suite (Quadrant) for real-time monitoring, QC, and compliance dashboards including AI Self Reporting (SOAR) natural language querying; and Submissions Suite for regional R3 regulatory compliance including RSI Management and TransformPV. Configuration Manager handles database setup. The company also provides comprehensive services including PV regulatory compliance consulting, safety database implementation and upgrades, data migration, PV reporting, hosting and managed services, and specialized Japan consulting. The platform reduces operational costs by 40% while ensuring regulatory compliance across global markets.
Differentiator
Problem solved
Functional benefit
Brands
- HiLIT Platform: AI-powered technological backbone for pharmacovigilance operations providing process automation
- Quadrant Suite
- TransformPV
- PVFilter
Products and services
- HiLIT Platform The technological backbone for all pharmacovigilance operations, providing process automation and intelligent case management across intake, processing, submission, and oversight for pharma companies and CROs.
- Intake Suite Intelligent case intake and AI-powered data extraction software for pharma PV teams covering literature, web forms, mailbox, mobile intake, structured/unstructured data, and query management; reduces manual processing 50–75%.
- Processing Suite (HiARSIC) Advanced case processing module with automated workflows, medical review streamlining, and consistent case assessment for pharma safety teams.
- Oversight Suite (Quadrant) Real-time monitoring and compliance dashboard software for PV operational excellence, including In-Line and Retro QC, Late Cases Analysis, CAPA Management, AI Self Reporting (SOAR), and PV Data Mart.
- Submissions Suite (HiDIS) Automated regulatory submissions software with global and regional R3 compliance capabilities, including RSI Management and TransformPV for FDA, EMA, PMDA, Korea, China, Russia, and LATAM.
- PV Regulatory Compliance Services Professional consulting services for PV regulatory compliance across FDA, EMA, PMDA, Health Canada, and R3 regulations for pharma companies and CROs.
- Safety Database Implementation & Upgrades End-to-end implementation and upgrade services for Argus Safety and other safety databases using a 5-stage methodology (preparation, blueprint, realization, transition, cutover) for pharma PV operations.
- Data Migration Services Complex multi-million record data migration services across safety systems (Argus, ARISg, AERS, LSMV, Trace, Perceive, and legacy systems) with zero data loss for PV operations.
- PV Reporting Services Comprehensive pharmacovigilance reporting services for PSUR, PBRER, PADERs and other periodic safety reports across all organization sizes and enterprise platforms.
- Hosting & Managed Services 24/7 managed services with Follow the Sun support, SLA adherence, cloud hosting on single-tenant environments, application management, and full client control for PV operations.
- Japan Consulting Services Specialized consulting services for the Japanese pharma market covering PMDA regulatory compliance, Argus J implementation, bilingual PV support, and regional R3 submissions.
Quantifiable outcome
- 60% reduction in case processing time
- +9 more outcomes
Companies that use Vitrana
Customer profileNamed customers17 records
Segments4 records
Ideal customer profiles3 records
Vitrana technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration20 records
AI capability7 records
Feature9 records
Vitrana partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- ParexelcoreParexel, a global clinical development partner headquartered in Raleigh, North Carolina, acquired Vitrana to expand its AI-enabled pharmacovigilance capabilities. The acquisition integrates Vitrana's intelligent automation platform with Parexel's patient safety services, enabling a single-partner model for pharmaceutical companies seeking integrated PV technology and services.
- Oracle Argus SafetycoreDeep integration partnership with Oracle Argus Safety platform. Vitrana's team includes former Oracle HSGBU architects who built Argus Safety Suite. Extensive experience with implementations, upgrades, data migrations, and customizations for Argus.
- MedidatacoreIntegration with Medidata clinical operations platform for seamless data flow between safety and clinical trial systems.
- Oracle ClinicalcoreIntegration with Oracle Clinical for unified clinical development and pharmacovigilance data management.
Scale indicators11 records
Recent moves7 records
Expansion highlights6 records
Vitrana competitors and assessment
Company assessmentDirect peers
- Oracle Health Sciences (Argus Safety): Oracle Argus Safety is the dominant on-premise safety database that Vitrana extends and integrates against. The team that built Argus now largely sits inside Vitrana, and the two are simultaneously partners and direct competitors as Argus evolves into a cloud platform.
- Veeva Systems (Vault Safety): Veeva Vault Safety is the leading cloud-native safety/case management platform competing directly with Argus and the integration layer Vitrana sells on top of it. Both target global pharma PV modernization and AI-driven case automation.
- ArisGlobal (LifeSphere Safety): ArisGlobals LifeSphere Safety/MV is a cloud-native pharmacovigilance suite competing head-on with Vitranas HiLIT platform for AI-driven case intake, processing, and regulatory submissions at large pharma and CROs.
- Sparta Systems (TrackWise, a Honeywell company): TrackWise Quality and Safety is an enterprise quality/PV platform used by life sciences manufacturers for case management, deviation handling, and compliance workflows that overlap with Vitranas PV oversight capabilities.
- Clario (formerly BioClinica): Clario provides clinical trial technology and safety services with overlap into PV case processing and regulatory submissions; it is also a Vitrana customer reference in the data provided.
Broad incumbents
- IQVIA (Safety & Regulatory): IQVIA is both a Vitrana customer (PV operations, data migration) and a broad incumbent offering safety technology and services at scale. Comparable as a one-stop PV services + technology provider to global pharma sponsors.
- ICON plc (PV Services): ICON, post-PRA Health Sciences and Symphony Health acquisitions, is a top-tier global CRO with end-to-end pharmacovigilance and safety database services, comparable to Vitrana/Parexels combined technology-and-services model.
- Labcorp (Covance Drug Development / early development PV): Labcorps Covance early development and clinical safety businesses include PV technology and managed services for global pharma sponsors, competing for the same end customers and budget as Vitranas offerings.
Emerging players
- MaxisIT: MaxisIT offers a clinical data analytics and risk-based monitoring platform used by large pharma, with overlapping PV signal detection and data integration capabilities adjacent to Vitranas PV Data Mart and analytics offerings.
- Phastar: Phastar is a specialized biometrics and PV services provider for clinical and post-marketing safety, with comparable focus on statistical analysis, aggregate reporting, and biostatistics for pharma safety teams.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Vitrana social profiles
Digital presenceVitrana compliance and trust
Trust signalCompliance1 record
Vitrana financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vitrana leadership team
Management profileNumber of profiles
Profiles12 records
Vitrana funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vitrana M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vitrana
What does Vitrana do?
Vitrana develops and sells the HiLIT Platform, an AI-powered pharmacovigilance technology suite that automates adverse event case intake, processing, quality control, regulatory submissions, and compliance oversight for pharmaceutical companies and CROs. The platform integrates directly with Argus Safety and ARISg databases and includes specialized modules for AI-driven RSI management, regional R3 submissions, natural language querying (SOAR), and PV data analytics. In parallel, Vitrana delivers professional consulting, implementation, data migration, and 24/7 managed services to operate drug safety systems.
Is Vitrana a public or private company?
Vitrana is a private company. It is classified as corporate owned and is currently acquired.
When was Vitrana founded?
Vitrana was founded in 2008. It employs 251 to 500 people.
Where is Vitrana based?
Vitrana is headquartered in Noida, India, in the Asia region.
How does Vitrana make money?
Four revenue lines are on record. Pharmaceutical Operations Software is the primary driver. The others are professional Services, managed Services and japan Consulting Services.
Who are Vitrana's main competitors?
Direct peers on record are Oracle Health Sciences (Argus Safety), Veeva Systems (Vault Safety), ArisGlobal (LifeSphere Safety), Sparta Systems (TrackWise, a Honeywell company) and Clario (formerly BioClinica). Broad incumbents are IQVIA (Safety & Regulatory), ICON plc (PV Services) and Labcorp (Covance Drug Development / early development PV). Emerging players are MaxisIT and Phastar.
Does Vitrana have an API?
No public API is recorded for Vitrana.
What industry is Vitrana in?
Vitrana's product category is Pharmacovigilance Software. Its primary akta.pro industry code is HLAGAJAK, Pharmacovigilance & Drug Safety Software, with a secondary code of HLAGAOAF, Pharmacovigilance, Drug Safety & Risk Management FSP. Its NAICS code is 541511 and its SIC code is 7372.